Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (RBR-6zfzs4j) titled 'Comparison of the effect of three Benznidazole formulations for the treatment of Chagas Disease' on Sept. 30.
Study Type: Intervention
Primary Sponsor: Scentryphar Pesquisa Clinica Ltda
Condition:
BMI-Age
M01.774.500
Intervention:
The in vivo study will be a randomized, open-label, single-center, crossover clinical trial using three 100 mg BZN tablet formulations: Lafepe, designated as the test formulation (T)
Elea, designated as reference formulation one (R1)
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 01/10/2022
Countries of Recruitment:
Brazil
To know more, visit https://ensai...